{"id":"https://openalex.org/W7204997078","doi":"https://doi.org/10.3390/ijms27209266","title":"Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan","display_name":"Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan","publication_year":2026,"publication_date":"2026-10-19","ids":{"openalex":"https://openalex.org/W7204997078","doi":"https://doi.org/10.3390/ijms27209266","pmid":"https://pubmed.ncbi.nlm.nih.gov/42942035","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13704960"},"language":"en","primary_location":{"id":"doi:10.3390/ijms27209266","doi":"https://doi.org/10.3390/ijms27209266","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209266","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ijms27209266","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048935798","display_name":"Tatyana E. Kornienko","orcid":"https://orcid.org/0000-0002-5427-9786","observed_orcids":["https://orcid.org/0000-0002-5427-9786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatyana E. Kornienko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5427-9786","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113878574","display_name":"Alexandra L. Zakharenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Alexandra L. Zakharenko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085427775","display_name":"Irina A. Chernyshova","orcid":"https://orcid.org/0000-0003-1934-5116","observed_orcids":["https://orcid.org/0000-0003-1934-5116"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irina A. Chernyshova","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1934-5116","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017098876","display_name":"Arina A. Chepanova","orcid":"https://orcid.org/0000-0003-0896-5299","observed_orcids":["https://orcid.org/0000-0003-0896-5299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arina A. Chepanova","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0896-5299","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024516955","display_name":"Nadezhda S. Dyrkheeva","orcid":"https://orcid.org/0000-0002-8360-1041","observed_orcids":["https://orcid.org/0000-0002-8360-1041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadezhda S. Dyrkheeva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120742066","display_name":"Alina A. Firsova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alina A. Firsova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133291356","display_name":"Artem D. Rogachev","orcid":"https://orcid.org/0000-0002-3338-8529","observed_orcids":["https://orcid.org/0000-0002-3338-8529"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Artem D. Rogachev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060382876","display_name":"Olga A. Luzina","orcid":"https://orcid.org/0000-0001-8627-3453","observed_orcids":["https://orcid.org/0000-0001-8627-3453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga A. Luzina","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8627-3453","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114608794","display_name":"Nelly A. Popova","orcid":"https://orcid.org/0009-0005-9280-8545","observed_orcids":["https://orcid.org/0009-0005-9280-8545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nelly A. Popova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048947700","display_name":"\u041c\u0430\u043a\u0441\u0438\u043c\u043e\u0432\u0430 \u0412\u0430\u0440\u0432\u0430\u0440\u0430 \u041f\u0430\u0432\u043b\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0003-0896-2952","observed_orcids":["https://orcid.org/0000-0003-0896-2952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Varvara P. Maksimova","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0896-2952","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103007720","display_name":"O. A. Vlasova","orcid":"https://orcid.org/0000-0002-1498-849X","observed_orcids":["https://orcid.org/0000-0002-1498-849X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga A. Vlasova","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1498-849X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042712816","display_name":"Valentina Petrovna Deryagina","orcid":"https://orcid.org/0000-0002-3204-3481","observed_orcids":["https://orcid.org/0000-0002-3204-3481"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentina P. Deryagina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149059223","display_name":"Alexander Rodnyy","orcid":"https://orcid.org/0000-0001-5739-4176","observed_orcids":["https://orcid.org/0000-0001-5739-4176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Rodnyy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5739-4176","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080317403","display_name":"Nariman Faridovich Salakhutdinov","orcid":"https://orcid.org/0000-0001-8512-4309","observed_orcids":["https://orcid.org/0000-0001-8512-4309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nariman F. Salakhutdinov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5001007906","display_name":"Olga I. Lavrik","orcid":"https://orcid.org/0000-0001-5980-8889","observed_orcids":["https://orcid.org/0000-0001-5980-8889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga I. Lavrik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5980-8889","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5113878574"],"corresponding_institution_ids":[],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.51179736,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"20","first_page":"9266","last_page":"9266"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/usnic-acid-derivatives","display_name":"usnic acid derivatives","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tdp1-inhibitors","display_name":"TDP1 inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/topoisomerase-i","display_name":"topoisomerase I","score":0.8309999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6480000019073486},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.6100000143051147},{"id":"https://openalex.org/keywords/lewis-lung-carcinoma","display_name":"Lewis lung carcinoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/antimetastatic-effect","display_name":"antimetastatic effect","score":0.753000020980835},{"id":"https://openalex.org/keywords/genotoxicity","display_name":"genotoxicity","score":0.8330000042915344},{"id":"https://openalex.org/keywords/epigenetic-effects","display_name":"epigenetic effects","score":0.8379999995231628},{"id":"https://openalex.org/keywords/intraperitoneal-administration","display_name":"intraperitoneal administration","score":0.781000018119812},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6100000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5090000033378601},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.9714999794960022},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6913999915122986},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.691100001335144},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5268999934196472},{"id":"https://openalex.org/C2777865847","wikidata":"https://www.wikidata.org/wiki/Q425894","display_name":"Trichostatin A","level":5,"score":0.4893999993801117},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4684999883174896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4453999996185303},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42669999599456787},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42089998722076416},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.38359999656677246},{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.3646000027656555},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.3490000069141388},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33340001106262207},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.3278999924659729},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.31839999556541443},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.2797999978065491},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2775999903678894},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.271699994802475},{"id":"https://openalex.org/C2776197502","wikidata":"https://www.wikidata.org/wiki/Q25326666","display_name":"Ehrlich ascites carcinoma","level":3,"score":0.2667999863624573},{"id":"https://openalex.org/C2776428644","wikidata":"https://www.wikidata.org/wiki/Q2126468","display_name":"Radiosensitizer","level":3,"score":0.2531000077724457},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2526000142097473},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.2524000108242035}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010727","descriptor_name":"Phosphoric Diester Hydrolases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018827","descriptor_name":"Carcinoma, Lewis Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3390/ijms27209266","doi":"https://doi.org/10.3390/ijms27209266","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209266","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},{"id":"doi:10.20944/preprints202608.2326.v1","doi":"https://doi.org/10.20944/preprints202608.2326.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202608.2326.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:13704960","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13704960/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13704960/pdf/ijms-27-09266.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Mol Sci","raw_type":"Text"},{"id":"pmid:42942035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42942035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of molecular sciences","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3390/ijms27209266","doi":"https://doi.org/10.3390/ijms27209266","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ijms27209266","pdf_url":null,"source":{"id":"https://openalex.org/S10623703","display_name":"International Journal of Molecular Sciences","issn_l":"1422-0067","issn":["1422-0067","1661-6596"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7420849108","display_name":null,"funder_award_id":"25-24-00247","funder_id":"https://openalex.org/F4320324099","funder_display_name":"Russian Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320321770","display_name":"Siberian Branch, Russian Academy of Sciences","ror":"https://ror.org/02frkq021"},{"id":"https://openalex.org/F4320324099","display_name":"Russian Science Foundation","ror":"https://ror.org/03y2gwe85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204997078.pdf","grobid_xml":"https://content.openalex.org/works/W7204997078.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W148050414","https://openalex.org/W1996715118","https://openalex.org/W2044025814","https://openalex.org/W2063909696","https://openalex.org/W2066357142","https://openalex.org/W2071125292","https://openalex.org/W2083116469","https://openalex.org/W2118792103","https://openalex.org/W2126673711","https://openalex.org/W2133554355","https://openalex.org/W2280392194","https://openalex.org/W2411203921","https://openalex.org/W2473917683","https://openalex.org/W2482186412","https://openalex.org/W2551275990","https://openalex.org/W2600452401","https://openalex.org/W2772666794","https://openalex.org/W2901006833","https://openalex.org/W2923229634","https://openalex.org/W2990791883","https://openalex.org/W3015646919","https://openalex.org/W3085570118","https://openalex.org/W3166499791","https://openalex.org/W3174005399","https://openalex.org/W3187362828","https://openalex.org/W4210752699","https://openalex.org/W4238301869","https://openalex.org/W4280589597","https://openalex.org/W4327971360","https://openalex.org/W4385516217","https://openalex.org/W4386826648","https://openalex.org/W4399625106","https://openalex.org/W4412430568","https://openalex.org/W7131066401"],"related_works":["https://openalex.org/W4416971668","https://openalex.org/W4386826648","https://openalex.org/W4414388917","https://openalex.org/W3175796231","https://openalex.org/W4391031951","https://openalex.org/W3187362828","https://openalex.org/W4394817013","https://openalex.org/W4400238788","https://openalex.org/W4402722680","https://openalex.org/W3129279480"],"abstract_inverted_index":{"Topotecan":[0],"inhibits":[1,27],"topoisomerase":[2],"1":[3,20],"(TOP1)":[4],"by":[5,17],"trapping":[6],"the":[7,32,44,100,128,137,142,177],"enzyme":[8],"in":[9,109],"a":[10,39,110,120,190],"DNA-cleavage":[11],"complex,":[12],"which":[13],"can":[14],"be":[15],"repaired":[16],"tyrosyl-DNA":[18],"phosphodiesterase":[19],"(TDP1).":[21],"The":[22],"usnic":[23],"acid":[24],"derivative":[25],"OL9-116":[26,51,61,131,188],"TDP1":[28,193],"and":[29,46,70,123,149,155,163],"thereby":[30],"enhances":[31],"antitumor":[33,154],"activity":[34],"of":[35,50,125,130,159],"topotecan,":[36],"making":[37],"it":[38],"promising":[40,191],"combination":[41,144,179,196],"partner.":[42],"However,":[43],"safety":[45],"optimal":[47],"administration":[48,87,108],"schedule":[49],"with":[52,80,176,181,197],"topotecan":[53,107,126,182],"have":[54],"not":[55],"been":[56],"characterized.":[57],"We":[58,97],"demonstrated":[59],"that":[60,105],"has":[62],"no":[63,167],"genotoxic":[64],"or":[65],"epigenetic":[66],"effects":[67],"using":[68],"Ames":[69],"CBMN":[71],"assays,":[72],"as":[73,75,189],"well":[74],"HeLa":[76],"trichostatin":[77],"A-inducible":[78],"cells":[79],"an":[81],"epigenetically":[82],"repressed":[83],"GFP":[84],"gene.":[85],"Intraperitoneal":[86],"was":[88,116],"found":[89],"to":[90],"provide":[91],"higher":[92],"bioavailability":[93],"than":[94,119],"intragastric":[95],"administration.":[96],"showed":[98],"on":[99],"RShM-5":[101],"cervical":[102],"cancer":[103],"model":[104],"repeated":[106],"clinically":[111,168],"relevant":[112],"low":[113],"single-dose":[114],"regimen":[115],"more":[117],"effective":[118],"single":[121],"injection,":[122],"addition":[124],"at":[127],"Tmax":[129],"enhanced":[132],"tumor":[133,147],"growth":[134],"inhibition.":[135],"In":[136],"Lewis":[138],"lung":[139,150],"carcinoma":[140],"model,":[141],"OL9-116\u2013topotecan":[143,178],"reduced":[145],"primary":[146],"mass":[148],"metastases,":[151],"enhancing":[152],"both":[153],"antimetastatic":[156],"effects.":[157],"Monitoring":[158],"hematological":[160],"parameters,":[161],"liver,":[162],"spleen":[164],"indices":[165],"revealed":[166],"significant":[169],"toxicity.":[170],"Moreover,":[171],"peripheral":[172],"blood":[173],"parameters":[174],"improved":[175],"compared":[180],"monotherapy.":[183],"Collectively,":[184],"these":[185],"findings":[186],"support":[187],"safe":[192],"inhibitor":[194],"for":[195],"topotecan.":[198]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-02T00:00:00"}
